Fantastic article but old. What I don’t understand is how did a drug with such huge potential run out of finding. It makes little sense to me. Maybe it got renewed interest with the way it fights the immune system for Covid and they renewed the patent pending issuing major news. Yes this whole stock is based on maybe but I’m a believer
If you were eyeing this ticker (genspera) when Dr. Dionne (a PHD in biochemistry and a formidable lab scientist) was ceo you would understand that nobody believed more in the strength and efficacy of mipsagargin. With that believe he tried to do more than what was possible with the resources available to him. His lack of finance and administration skills were his down fall. Some real toxic financing deals and over promising clinical trials and drug studies that he could not get accomplished did him in. FLG and Chris Lowe took over. However, nothing can be sad bad about DR. Dionne and what he did to get Genspera off the ground. He was there from the start in 2003 until 2016 and was a knowledgeable cheerleader for the attributes of mipsagargin.
100x stronger then Chemo, does no damage to healthy cells- what are the Companies like Gilead and Pfizer waiting for? This is an opportunity, either as a partnership or as a takeover candidate.
News 
Market Data 
Discover 
